HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.

The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocardi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephen T Chambers, David Murdoch, Arthur Morris, David Holland, Paul Pappas, Manel Almela, Nuria Fernández-Hidalgo, Benito Almirante, Emilio Bouza, Davide Forno, Ana del Rio, Margaret M Hannan, John Harkness, Zeina A Kanafani, Tahaniyat Lalani, Selwyn Lang, Nigel Raymond, Kerry Read, Tatiana Vinogradova, Christopher W Woods, Dannah Wray, G Ralph Corey, Vivian H Chu, International Collaboration on Endocarditis Prospective Cohort Study Investigators
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1b602b0ad0f64ccbb1724256026ba2de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b602b0ad0f64ccbb1724256026ba2de
record_format dspace
spelling oai:doaj.org-article:1b602b0ad0f64ccbb1724256026ba2de2021-11-18T07:45:21ZHACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.1932-620310.1371/journal.pone.0063181https://doaj.org/article/1b602b0ad0f64ccbb1724256026ba2de2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23690995/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocarditis (HE) in a large multi-national cohort. Patients hospitalized with definite or possible infective endocarditis by the International Collaboration on Endocarditis Prospective Cohort Study in 64 hospitals from 28 countries were included and characteristics of HE patients compared with IE due to other pathogens. Of 5591 patients enrolled, 77 (1.4%) had HE. HE was associated with a younger age (47 vs. 61 years; p<0.001), a higher prevalence of immunologic/vascular manifestations (32% vs. 20%; p<0.008) and stroke (25% vs. 17% p = 0.05) but a lower prevalence of congestive heart failure (15% vs. 30%; p = 0.004), death in-hospital (4% vs. 18%; p = 0.001) or after 1 year follow-up (6% vs. 20%; p = 0.01) than IE due to other pathogens (n = 5514). On multivariable analysis, stroke was associated with mitral valve vegetations (OR 3.60; CI 1.34-9.65; p<0.01) and younger age (OR 0.62; CI 0.49-0.90; p<0.01). The overall outcome of HE was excellent with the in-hospital mortality (4%) significantly better than for non-HE (18%; p<0.001). Prosthetic valve endocarditis was more common in HE (35%) than non-HE (24%). The outcome of prosthetic valve and native valve HE was excellent whether treated medically or with surgery. Current treatment is very successful for the management of both native valve prosthetic valve HE but further studies are needed to determine why HE has a predilection for younger people and to cause stroke. The small number of patients and observational design limit inferences on treatment strategies. Self selection of study sites limits epidemiological inferences.Stephen T ChambersDavid MurdochArthur MorrisDavid HollandPaul PappasManel AlmelaNuria Fernández-HidalgoBenito AlmiranteEmilio BouzaDavide FornoAna del RioMargaret M HannanJohn HarknessZeina A KanafaniTahaniyat LalaniSelwyn LangNigel RaymondKerry ReadTatiana VinogradovaChristopher W WoodsDannah WrayG Ralph CoreyVivian H ChuInternational Collaboration on Endocarditis Prospective Cohort Study InvestigatorsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 5, p e63181 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Stephen T Chambers
David Murdoch
Arthur Morris
David Holland
Paul Pappas
Manel Almela
Nuria Fernández-Hidalgo
Benito Almirante
Emilio Bouza
Davide Forno
Ana del Rio
Margaret M Hannan
John Harkness
Zeina A Kanafani
Tahaniyat Lalani
Selwyn Lang
Nigel Raymond
Kerry Read
Tatiana Vinogradova
Christopher W Woods
Dannah Wray
G Ralph Corey
Vivian H Chu
International Collaboration on Endocarditis Prospective Cohort Study Investigators
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
description The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocarditis (HE) in a large multi-national cohort. Patients hospitalized with definite or possible infective endocarditis by the International Collaboration on Endocarditis Prospective Cohort Study in 64 hospitals from 28 countries were included and characteristics of HE patients compared with IE due to other pathogens. Of 5591 patients enrolled, 77 (1.4%) had HE. HE was associated with a younger age (47 vs. 61 years; p<0.001), a higher prevalence of immunologic/vascular manifestations (32% vs. 20%; p<0.008) and stroke (25% vs. 17% p = 0.05) but a lower prevalence of congestive heart failure (15% vs. 30%; p = 0.004), death in-hospital (4% vs. 18%; p = 0.001) or after 1 year follow-up (6% vs. 20%; p = 0.01) than IE due to other pathogens (n = 5514). On multivariable analysis, stroke was associated with mitral valve vegetations (OR 3.60; CI 1.34-9.65; p<0.01) and younger age (OR 0.62; CI 0.49-0.90; p<0.01). The overall outcome of HE was excellent with the in-hospital mortality (4%) significantly better than for non-HE (18%; p<0.001). Prosthetic valve endocarditis was more common in HE (35%) than non-HE (24%). The outcome of prosthetic valve and native valve HE was excellent whether treated medically or with surgery. Current treatment is very successful for the management of both native valve prosthetic valve HE but further studies are needed to determine why HE has a predilection for younger people and to cause stroke. The small number of patients and observational design limit inferences on treatment strategies. Self selection of study sites limits epidemiological inferences.
format article
author Stephen T Chambers
David Murdoch
Arthur Morris
David Holland
Paul Pappas
Manel Almela
Nuria Fernández-Hidalgo
Benito Almirante
Emilio Bouza
Davide Forno
Ana del Rio
Margaret M Hannan
John Harkness
Zeina A Kanafani
Tahaniyat Lalani
Selwyn Lang
Nigel Raymond
Kerry Read
Tatiana Vinogradova
Christopher W Woods
Dannah Wray
G Ralph Corey
Vivian H Chu
International Collaboration on Endocarditis Prospective Cohort Study Investigators
author_facet Stephen T Chambers
David Murdoch
Arthur Morris
David Holland
Paul Pappas
Manel Almela
Nuria Fernández-Hidalgo
Benito Almirante
Emilio Bouza
Davide Forno
Ana del Rio
Margaret M Hannan
John Harkness
Zeina A Kanafani
Tahaniyat Lalani
Selwyn Lang
Nigel Raymond
Kerry Read
Tatiana Vinogradova
Christopher W Woods
Dannah Wray
G Ralph Corey
Vivian H Chu
International Collaboration on Endocarditis Prospective Cohort Study Investigators
author_sort Stephen T Chambers
title HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
title_short HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
title_full HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
title_fullStr HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
title_full_unstemmed HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
title_sort hacek infective endocarditis: characteristics and outcomes from a large, multi-national cohort.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/1b602b0ad0f64ccbb1724256026ba2de
work_keys_str_mv AT stephentchambers hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT davidmurdoch hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT arthurmorris hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT davidholland hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT paulpappas hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT manelalmela hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT nuriafernandezhidalgo hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT benitoalmirante hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT emiliobouza hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT davideforno hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT anadelrio hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT margaretmhannan hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT johnharkness hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT zeinaakanafani hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT tahaniyatlalani hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT selwynlang hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT nigelraymond hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT kerryread hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT tatianavinogradova hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT christopherwwoods hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT dannahwray hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT gralphcorey hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT vivianhchu hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
AT internationalcollaborationonendocarditisprospectivecohortstudyinvestigators hacekinfectiveendocarditischaracteristicsandoutcomesfromalargemultinationalcohort
_version_ 1718422958172536832